Severe Obesity Clinical Trial
Official title:
Correlation Between Body Composition and the Muscle Strength in Severe Obese Patients in the Postoperative of Bariatric Surgery
Excessive fat mass (FM) contributes to changes in the strength and endurance of skeletal muscles. Mid-thigh muscle mass is approximately 2.5 times that of fat mass, but individuals who are obese have increased intra- (fat within muscle cells) and intermuscular fat (fat between muscle cells), establishing a negative influence on strength generation capacity and functional independence. The functional capacity of a skeletal muscle can be assessed based on the muscle's ability to produce strength. The relevance of this study is to identify/analyze the changes in segmental body composition (BC) which might better determine the association between fat free mass (FFM) of the lower limbs and maximum voluntary contraction (MVC), 36 months after bariatric surgery. This study was elaborated and will be performed at the Clinical Hospital in the Medical School of the University of Sao Paulo (HCFMUSP). The patients involved will receive the Informed Consent Form. The sample, consists of 155 adults selected at the ambulatory of the Bariatric and Metabolic Surgery Unit of the Department of Gastroenterology of HCFMUSP in the periods: preoperative, 6 and 36 months after surgery. Patients of both sexes, above 18 years of age, will undergo bariatric surgery performed at the institution. Adult patients over 60 years old, undergoing revision surgery and other surgical techniques will be excluded. Anthropometric variables will be obtained on the same day as the evaluation of BC by trained evaluators. The BC will be measured by In Body 230. BMI (kg/m2) shall be determined by dividing body weight (kg) by height (m) squared. Evaluation of Body Composition and Muscle Strength will be held between 8:00 am and 10:00 am in the Laboratory of Exercise and Movement Studies at the Institute of Orthopedics and Traumatology of FMUSP. BC measurements as FM (% and kg), FFM (% and kg), will be obtained by the indirect noninvasive method of electrical bioimpedance. The dynamometer will be used to evaluate muscle strength extension (Ext) and flexion (Flex) MVC torques for both legs will be carried. The MVC assessed variables should be absolute Ext and Flex torques (Nm), Ext and Flex torques relative to the body weight (Nm/Bw) and Ext and Flex torques relative to FFM (Nm/FFM).
Anthropometric Assessment Anthropometric variables will be obtained on the same day as the
evaluation of BC by trained evaluators. The body weight (kg) will be measured by In Body 230,
2.0, (Biospace Seoul, Korea). The patient should be in the orthostatic position, facing the
display, in the center of the scale, barefoot, in light clothes. The height measurement (m)
will be performed in a stadiometer coupled to the scale W 300, Class III, with a maximum
capacity of 2m. The patient will be kept with his back to the meter, with the feet united, in
an erect position, looking at horizon and arms extended to the side of the body. The reading
will be made in the nearest centimeter when the horizontal rod of the vertical bar of the
stature scale rests against the individual's head. BMI (kg/m2) will be determined by dividing
body weight (kg) by height (m) squared.
Bioimpedance Body composition will be determined by bioelectrical impedance analysis (BIA)
under constant conditions (with subjects appropriately hydrated and at the same time of
day).The body composition analyzer (InBody230, Biospace Co., Gangnam-gu, Seoul, South Korea)
was a segmental impedance device that uses a tetrapolar 8-point tactile electrode system, and
the measured weight range was 10 to 250 kg. Impedance measurements were performed by
utilizing 2 different frequencies (20 and 100 kHz) at each segment (the right arm, left arm,
trunk, right leg, and left leg). The participant will be positioned in orthostatic position
on a platform with lower electrodes for the feet and two brackets (the upper electrodes)
gripped on hands. Data output was calculated in percentages (%) and included FM, FFM, trunk
FFM, and appendicular FFM (the sum of the FFM values for the right arm, left arm, right leg,
and left leg).
Isokinetic dynamometer The muscular strength evaluation will be performed on the isokinetic
dynamometer, Biodex ® Multi-joint System 3 (Biodex Medical Systems Inc, Shirley, New York,
USA). The dynamometer is calibrated thirty minutes before the start of the tests.
Participants are positioned for evaluation in the concentric / concentric mode of knee joint
extension and flexion movements. Individuals remain seated with their hip at 90º of flexion,
affixed to the chair with chest X-belts, a strap around the pelvic girdle, a strap over the
distal third of the thigh and one at the distal third of the assessed leg, way to free the
movements of the ankle.
All participants are instructed to perform four movements with submaximal force to
familiarize themselves with the equipment. The test is performed first on the dominant limb
and later on the non-dominant limb. The assessed limb is positioned with the lateral femoral
condyle (axis of the knee joint movement) aligned to the mechanical axis of the dynamometer.
The member that is not being evaluated will be aligned with the other member. The volunteers
are instructed to perform two sets of 4 uninterrupted repetitions of knee extension and
flexion with interval of 60 seconds. Throughout the period of the test, standardized and
constant verbal encouragement is performed to obtain as much force as possible during
contractions.
The tests are performed with concentric movements of flexion and extension of the knee,
starting from 90º of flexion and reaching 20º of extension, with correction of the force of
gravity.
The angular velocity used will be 60 degrees per second (60º / s).
The variables that will be obtained through the evaluation of muscular strength are:
Torque Peak (Nm): is the maximum force reached in each of the repetitions in which the test
was performed. The peak torque represents the largest muscle contraction in the arc of
movement and corresponds to the highest point of the force x distance curve.
Peak torque relative to body weight (Nm / kg): maximum force corrected for body weight, the
result being expressed in percent newton-kilogram.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03690752 -
Adherence to Walking on an Alter G Anti-Gravity Treadmill
|
N/A | |
Active, not recruiting |
NCT02767505 -
Bypass Equipoise Sleeve Trial (BEST)
|
N/A | |
Recruiting |
NCT05786092 -
Impact of Telemonitoring on Metabolic Variables in Severe Obesity
|
N/A | |
Active, not recruiting |
NCT03249441 -
Compassion-Focused Therapy for People With Severe Obesity.
|
N/A | |
Terminated |
NCT04626232 -
Comparison of the Sleeve Gastrectomy Technique With a Nissen Fundoplication Added to the Conventional Sleeve Gastrectomy Technique in Morbidly Obese Patients
|
N/A | |
Completed |
NCT02952963 -
Effect of Bile Acids and Bile Acid Sequstrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass
|
Phase 4 | |
Active, not recruiting |
NCT02374632 -
Gut Hormones as Mediators of Different Weight Loss Responses After Roux-en-Y Gastric Bypass
|
Phase 4 | |
Active, not recruiting |
NCT04165694 -
Single Anastomosis Duodenal Ileal Bypass (SADI) for Sleeve Revision
|
N/A | |
Not yet recruiting |
NCT06162715 -
GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Feasibility Trial
|
Phase 2 | |
Completed |
NCT05409612 -
Trial Assessing the Immunogenicity and Safety of Two Influenza Vaccine Strategies Among Severe Obese Adult Patients
|
Phase 3 | |
Completed |
NCT03638895 -
Energy Expenditure From ECAL Indirect Calorimeter in a Multicomponent Weight Management Service
|
N/A | |
Not yet recruiting |
NCT05493592 -
Pigeon Peas (Cajanus Cajan) : a Natural Anti-inflammatory Facilitating Weight Loss in Obese Patients Returning to Sport?
|
N/A | |
Completed |
NCT02823561 -
Garcinia Mangostana Extracts in the Management of Weight Loss
|
Phase 4 | |
Completed |
NCT02340247 -
Effects of Bile Acids on GLP-1 Secretion After Roux-en-Y Gastric Bypass
|
Phase 4 | |
Recruiting |
NCT02076880 -
SLEEVEDIAB To Explore the Early and Late Metabolic Effects of Sleeve Gastrectomy in Obese Patients
|
N/A | |
Completed |
NCT04042493 -
Connect for Health Pediatric Weight Management Program
|
N/A | |
Completed |
NCT05341414 -
Trajectories of Resilience and Bariatric Surgery Outcomes
|
||
Recruiting |
NCT02710786 -
Comorbidity After Gastric Bypass
|
||
Recruiting |
NCT02409160 -
Sleep and Immune Response in Severe Obese Patients Undergoing Bariatric Surgery.
|
N/A | |
Completed |
NCT00623792 -
Study on Impact of Lifestyle Change and Weight Loss Before Bariatric Surgery
|
N/A |